Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) EPS (Weighted Average and Diluted) (2021 - 2025)

Historic EPS (Weighted Average and Diluted) for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to $0.06.

  • Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) rose 11818.18% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 7891.57%. This contributed to the annual value of -$1.16 for FY2024, which is 6937.16% up from last year.
  • Latest data reveals that Arcutis Biotherapeutics reported EPS (Weighted Average and Diluted) of $0.06 as of Q3 2025, which was up 11818.18% from -$0.13 recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) registered a high of $0.06 during Q3 2025, and its lowest value of -$1.89 during Q3 2022.
  • Over the past 5 years, Arcutis Biotherapeutics' median EPS (Weighted Average and Diluted) value was -$0.76 (recorded in 2021), while the average stood at -$0.79.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) plummeted by 6710.53% in 2022, and later skyrocketed by 11818.18% in 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$1.43 in 2021, then rose by 20.28% to -$1.14 in 2022, then soared by 48.25% to -$0.59 in 2023, then surged by 84.88% to -$0.09 in 2024, then soared by 167.27% to $0.06 in 2025.
  • Its last three reported values are $0.06 in Q3 2025, -$0.13 for Q2 2025, and -$0.2 during Q1 2025.